Recent studies have demonstrated that immunostaining for KRT7 and 20 can effectively differentiate primary ovarian carcinomas from metastatic carcinomas originating from the gastrointestinal tract and pancreas, which clinically resemble primary ovarian carcinoma (83). Here, KRT7 is linked to ovarian carcinoma.